57 related articles for article (PubMed ID: 6305169)
1. A peptide formed by fibrinolysis increases microvascular permeability and inhibits angiotensin converting enzyme.
Saldeen T; Ryan JW; Ragnarsson U
Adv Exp Med Biol; 1983; 156 (Pt B)():829-34. PubMed ID: 6305169
[No Abstract] [Full Text] [Related]
2. Enhancement of the permeability-increasing effect of bradykinin and substance P by a peptide derived from fibrinogen.
Eriksson M; Gerdin B; Saldeen T
Int J Microcirc Clin Exp; 1983; 2(1):53-9. PubMed ID: 6206007
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme dependent and non-dependent effects of a fibrinogen-derived pentapeptide on microvascular permeability in rat skin.
Eriksson M; Gerdin B; Saldeen T
Ups J Med Sci; 1983; 88(2):95-101. PubMed ID: 6316608
[TBL] [Abstract][Full Text] [Related]
4. Fibrin-derived vasoactive peptides release histamine.
Eriksson M; Saldeen K; Saldeen T; Strandberg K; Wallin R
Int J Microcirc Clin Exp; 1983; 2(4):337-45. PubMed ID: 6206010
[TBL] [Abstract][Full Text] [Related]
5. Structural requirements for microvascular permeability-increasing ability of peptides. Studies on analogues of a fibrinogen pentapeptide fragment.
Gerdin B; Lindeberg G; Ragnarsson U; Saldeen T; Wallin R
Biochim Biophys Acta; 1983 Jun; 757(3):366-70. PubMed ID: 6849982
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of the flavonoid O-(beta-hydroxyethyl)-rutoside on increased microvascular permeability induced by various agents in rat skin.
Gerdin B; Svensjö E
Int J Microcirc Clin Exp; 1983; 2(1):39-46. PubMed ID: 6088413
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of vasoactive peptides derived from fibrin or fibrinogen degraded by plasmin.
Belew M; Gerdin B; Lindeberg G; Porath J; Saldeen T; Wallin R
Biochim Biophys Acta; 1980 Feb; 621(2):169-78. PubMed ID: 7353036
[No Abstract] [Full Text] [Related]
8. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
[TBL] [Abstract][Full Text] [Related]
9. [On the biological properties of some fibrinogen degradation products (FDP)].
Malofiejew M
Rocz Akad Med Im Juliana Marchlewskiego Bialymst Suppl; 1968; 23():1-65. PubMed ID: 4310706
[No Abstract] [Full Text] [Related]
10. On the capillary permeability enhancing activity of isolated fibrinopeptides and their role in the physiology of the blood capillary wall.
Copley AL; Hanig JP; Luchini BW; Allen RL
Bibl Anat; 1967; 9():475-81. PubMed ID: 6029898
[No Abstract] [Full Text] [Related]
11. Vasoactive peptides derived from degradation of fibrinogen and fibrin.
Saldeen T
Ann N Y Acad Sci; 1983 Jun; 408():424-37. PubMed ID: 6575698
[No Abstract] [Full Text] [Related]
12. Effect of fibrin degradation products on microvascular permeability.
Gerdin B; Saldeen T
Thromb Res; 1978 Dec; 13(6):995-1006. PubMed ID: 749269
[No Abstract] [Full Text] [Related]
13. A peptide derived from fibrin(ogen) inhibits angiotensin converting enzyme and potentiates the effects of bradykinin.
Saldeen T; Ryan JW; Berryer P
Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):465-70. PubMed ID: 6275568
[No Abstract] [Full Text] [Related]
14. Effect of a fibrin(ogen)-derived vasoactive peptide on polymorphonuclear leukocyte emigration.
Saldeen K; Christie N; Nelson WR; Movat HZ
Thromb Res; 1985 Jan; 37(1):85-9. PubMed ID: 2984802
[TBL] [Abstract][Full Text] [Related]
15. [T-kinin-induced increase in airway vascular permeability and its modulation by angiotensin-converting enzyme].
Takeda Y; Tamaoki J; Yamawaki I; Chiyotani A; Konno K
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):627-31. PubMed ID: 8741526
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibitors potentiate the vasorelaxant effect of fibrinogen-derived peptide 6A.
Saldeen K; Lawson DL; Mehta JL
Thromb Res; 1991 Jan; 61(1):81-5. PubMed ID: 1850558
[No Abstract] [Full Text] [Related]
17. Effects of proteolytic degradation products of human fibrinogen and of human factor VIII on platelet aggregation and vascular permeability.
Stachurska J; Lopaciuk S; Gerdin B; Saldeen T; Korościk A; Kopeć M
Thromb Res; 1979; 15(5-6):663-72. PubMed ID: 494170
[No Abstract] [Full Text] [Related]
18. Role of bradykinin generating and degrading systems in the vascular permeability response induced with kaolin in rats.
Kumakura S; Tsurufuji S; Kurooka S; Sunahara N
J Pharmacol Exp Ther; 1987 Dec; 243(3):1067-73. PubMed ID: 3320343
[TBL] [Abstract][Full Text] [Related]
19. Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen.
Sueishi K; Nanno S; Tanaka K
Thromb Haemost; 1981 Feb; 45(1):90-4. PubMed ID: 7245130
[TBL] [Abstract][Full Text] [Related]
20. [Effects of enalaprilat on postischemic microvascular hyperpermeability in isolated working rat hearts].
Di Napoli P; Volpe S; Taccardi AA; Tiloca P; Maggi A; Di Crecchio A; Spina R; Di Muzio M; Barsotti A
Cardiologia; 1998 Dec; 43(12):1379-81. PubMed ID: 9988948
[No Abstract] [Full Text] [Related]
[Next] [New Search]
